免疫疾病中的代谢物衍生损伤相关的分子模式
Na Kang1,2, Zhenglin Ji1, Yuxin Li1
1State Key Laboratory of Membrane Biology, School of Life Sciences, Institute for Immunology, Beijing Advanced Innovation Center for Structural Biology, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
The FEBS journal
|July 11, 2023
概括
来自代谢途径的代谢衍生危险信号 (DAMPs) 可以加剧炎症和免疫疾病. 针对这些DAMP为免疫病提供了新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 分子生物学分子生物学
背景情况:
- 与损伤相关的分子模式 (DAMPs) 是从死细胞释放出来的内源分子,激活免疫反应.
- 如果无法清除DAMP,可能导致慢性炎症,从而导致免疫性疾病的发病.
- 代谢物衍生的DAMP代表了这些信号分子的新确定的类别.
研究的目的:
- 审查在炎症中由代谢物衍生的DAMP的分子机制.
- 探索它们在免疫性疾病病理学中的作用.
- 突出针对这些DAMP的临床干预措施.
主要方法:
- 关于代谢物衍生的DAMPs的研究的文献综述.
- 对参与DAMP生成和信号传递的分子通路的分析.
- 目前和潜在的治疗策略的总结.
主要成果:
- 由脂质,葡萄糖,核酸和氨基酸代谢产生的代谢衍生 DAMP 加剧炎症反应.
- 这些DAMP与各种免疫性疾病的病理学有关.
- 目前正在研究直接和间接的临床干预措施,以抵消其影响.
结论:
- 了解代谢物衍生的DAMP对于理解免疫性疾病的发展至关重要.
- 针对这些特定的DAMP有望为新的治疗干预措施提供希望.
- 需要进一步的研究来开发针对免疫相关疾病的有效治疗方法.
相关概念视频
Antigens Involved in Adaptive Immunity
554
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
554
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Autoimmune Disorders
511
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
511
Antigen Processing Pathways
1.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.1K
Allergic Drug Reactions
895
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
895


